Literature DB >> 32332909

Open science takes on the coronavirus pandemic.

Mark Zastrow.   

Abstract

Entities:  

Keywords:  Biotechnology; Diseases; Research data; SARS-CoV-2

Mesh:

Year:  2020        PMID: 32332909     DOI: 10.1038/d41586-020-01246-3

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  12 in total

Review 1.  Opportunities and Risks for Research Biobanks in the COVID-19 Era and Beyond.

Authors:  Daniel Simeon-Dubach; Marianne K Henderson
Journal:  Biopreserv Biobank       Date:  2020-10-08       Impact factor: 2.300

Review 2.  Antibacterial and Antiviral Functional Materials: Chemistry and Biological Activity toward Tackling COVID-19-like Pandemics.

Authors:  Bhuvaneshwari Balasubramaniam; Sudhir Ranjan; Mohit Saraf; Prasenjit Kar; Surya Pratap Singh; Vijay Kumar Thakur; Anand Singh; Raju Kumar Gupta
Journal:  ACS Pharmacol Transl Sci       Date:  2020-12-29

3.  COVID-19, Climate Change, and Renewable Energy Research: We Are All in This Together, and the Time to Act Is Now.

Authors:  Song Jin
Journal:  ACS Energy Lett       Date:  2020-05-08       Impact factor: 23.101

4.  3D Printing Challenges in Enabling Rapid Response to Public Health Emergencies.

Authors:  Dingyi Wang; Junpeng Zhang; Qian Liu; Bolei Chen; Yong Liang; Ligang Hu; Guibin Jiang
Journal:  Innovation (N Y)       Date:  2020-11-03

5.  Covid-19 Response From Global Makers: The Careables Cases of Global Design and Local Production.

Authors:  Barbara Kieslinger; Teresa Schaefer; Claudia Magdalena Fabian; Elisabetta Biasin; Enrico Bassi; Ricardo Ruiz Freire; Nadine Mowoh; Nawres Arif; Paulien Melis
Journal:  Front Sociol       Date:  2021-03-18

6.  Scenario analysis of COVID-19 transmission dynamics in Malaysia with the possibility of reinfection and limited medical resources scenarios.

Authors:  Amer M Salman; Issam Ahmed; Mohd Hafiz Mohd; Mohammad Subhi Jamiluddin; Mohammed Ali Dheyab
Journal:  Comput Biol Med       Date:  2021-04-07       Impact factor: 6.698

7.  A Quantitative Modeling and Simulation Framework to Support Candidate and Dose Selection of Anti-SARS-CoV-2 Monoclonal Antibodies to Advance Bamlanivimab Into a First-in-Human Clinical Trial.

Authors:  Emmanuel Chigutsa; Eric Jordie; Matthew Riggs; Ajay Nirula; Ahmed Elmokadem; Tim Knab; Jenny Y Chien
Journal:  Clin Pharmacol Ther       Date:  2021-11-17       Impact factor: 6.903

8.  Public mobility data enables COVID-19 forecasting and management at local and global scales.

Authors:  Cornelia Ilin; Sébastien Annan-Phan; Xiao Hui Tai; Shikhar Mehra; Solomon Hsiang; Joshua E Blumenstock
Journal:  Sci Rep       Date:  2021-06-29       Impact factor: 4.379

9.  Where Does Open Science Lead Us During a Pandemic? A Public Good Argument to Prioritize Rights in the Open Commons.

Authors:  Benjamin Capps
Journal:  Camb Q Healthc Ethics       Date:  2020-06-05       Impact factor: 1.566

10.  Does open data boost journal impact: evidence from Chinese economics.

Authors:  Liwei Zhang; Liang Ma
Journal:  Scientometrics       Date:  2021-02-14       Impact factor: 3.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.